Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Reinmuth

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
ESMO Open|May 2, 2018
New data: new options for front-line therapy in NSCLC?Niels Reinmuth
Deutsche Medizinische Wochenschrift (1946)|March 9, 2026
[Thoracic oncology]Niels Reinmuth
Annals of Palliative Medicine|August 22, 2022
Lessons from STIMULI: who benefits from consolidation nivolumab and ipilimumab in limited-disease small-cell lung cancer after chemo-radiotherapy?Niels Reinmuth
Deutsche Medizinische Wochenschrift (1946)|December 3, 2019
[Lung Cancer screening? Who should get it and how it should be done]Niels Reinmuth
Oncology Research and Treatment|June 5, 2016
Immunotherapy for Lung CancerNiels Reinmuth, Martin Reck
Zentralblatt Fur Chirurgie|February 28, 2018
[Small Cell Lung Cancer]Niels Reinmuth, Hans Hoffmann
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2018
Breaking the Glass Ceiling of Overall Survival in Non-Small-Cell Lung CancerNiels Reinmuth, Martin Reck
Progress in Tumor Research|September 19, 2015
Combinations TherapiesNiels Reinmuth, Martin Reck
European Journal of Cancer (Oxford, England : 1990)|January 9, 2021
Shall we use steroids when treating patients with lung cancer with checkpoint inhibitors?Niels Reinmuth, Martin Schuler
Der Pneumologe|October 19, 2020
[Pulmonary involvement in cancers]Niels Reinmuth, Sarah-Christin Mavi
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
ESMO Open|May 2, 2018
New data: new options for front-line therapy in NSCLC?Niels Reinmuth
Deutsche Medizinische Wochenschrift (1946)|March 9, 2026
[Thoracic oncology]Niels Reinmuth
Annals of Palliative Medicine|August 22, 2022
Lessons from STIMULI: who benefits from consolidation nivolumab and ipilimumab in limited-disease small-cell lung cancer after chemo-radiotherapy?Niels Reinmuth
Deutsche Medizinische Wochenschrift (1946)|December 3, 2019
[Lung Cancer screening? Who should get it and how it should be done]Niels Reinmuth
Oncology Research and Treatment|June 5, 2016
Immunotherapy for Lung CancerNiels Reinmuth, Martin Reck
Zentralblatt Fur Chirurgie|February 28, 2018
[Small Cell Lung Cancer]Niels Reinmuth, Hans Hoffmann
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2018
Breaking the Glass Ceiling of Overall Survival in Non-Small-Cell Lung CancerNiels Reinmuth, Martin Reck
Progress in Tumor Research|September 19, 2015
Combinations TherapiesNiels Reinmuth, Martin Reck
European Journal of Cancer (Oxford, England : 1990)|January 9, 2021
Shall we use steroids when treating patients with lung cancer with checkpoint inhibitors?Niels Reinmuth, Martin Schuler
Der Pneumologe|October 19, 2020
[Pulmonary involvement in cancers]Niels Reinmuth, Sarah-Christin Mavi
Pageof 14